✦ LIBER ✦

P03-303 - Improvement in patient symptoms and functioning during long-term treatment with olanzapine long-acting injection (OLAI)

✍ Scribed by Peuskens, J.; Porsdal, V.; Pecenak, J.; Handest, P.; D’yachkova, Y.; Brousil, R.; Casillas, M.; Deberdt, W.

Book ID: 123178276
Publisher: Elsevier Science
Year: 2011
Tongue: French
Weight: 14 KB
Volume: 26
Category: Article
ISSN: 0924-9338
DOI: 10.1016/S0924-9338(11)73177-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Schizophrenia symptoms and functioning i

Schizophrenia symptoms and functioning in patients receiving long-term treatment with olanzapine long-acting injection formulation: a pooled analysis

✍ Joseph Peuskens, Vibeke Porsdal, Jan Pecenak, Peter Handest… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 212 KB

Poster #207 LONG-TERM FUNCTIONAL IMPROVE

Poster #207 LONG-TERM FUNCTIONAL IMPROVEMENTS IN THE 2-YEAR TREATMENT OF SCHIZOPHRENIA OUTPATIENTS WITH OLANZAPINE LONG-ACTING INJECTION

✍ Haya Ascher-Svanum; Diego Novick; Josep M. Haro; Jordan Bertsch; David McDonnell 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB

P03-288 - Improvement of positive and ne

P03-288 - Improvement of positive and negative symptoms in patients with schizophrenia, under risperidone long acting injection (RLAI) treatment

✍ Moruzzi, E. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 French ⚖ 11 KB

Improved symptom control, functioning an

Improved symptom control, functioning and satisfaction in French patients treated with long-acting injectable risperidone

✍ P.-M. Llorca; P. Bouhours; V. Moreau-Mallet 📂 Article 📅 2008 🏛 Masson Editeur 🌐 French ⚖ 379 KB

P-13-12 - Long-term treatment-emergent d

P-13-12 - Long-term treatment-emergent dyskinetic symptoms in patients treated with olanzapine and haloperidol

✍ J. Street; R. Tamura; T. Sanger; G. Tollefson 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Comparison of metabolic changes in patie

Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine

✍ David P. McDonnell; Ludmila A. Kryzhanovskaya; Fangyi Zhao; Holland C. Detke; Pe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 1 views

Metabolic changes were examined in patients with schizophrenia during treatment with either oral olanzapine or olanzapine long‐acting injection (LAI). Data were collected from patients who had been stabilized on oral olanzapine (10, 15, or 20 mg/day) for ≥4 weeks and then randomized to either contin